During the past decade, Recherches Neuro-Hippocampe conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Recherches Neuro-Hippocampe" are "Alzheimer Disease" (2 trials). Many other conditions were trialed in "Recherches Neuro-Hippocampe" in a lesser frequency.

Most popular intervention types in "Recherches Neuro-Hippocampe" are "Drug" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Azeliragon" (1 trials), "Montelukast buccal film" (1 trials), "Placebo" (1 trials) and "Placebo buccal film" (1 trials). Other intervention names were less common.

The vast majority of trials in "Recherches Neuro-Hippocampe" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Recherches Neuro-Hippocampe". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Recherches Neuro-Hippocampe, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Recherches Neuro-Hippocampe, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".